Delhi Tramadol Premix Interception Leads Police to Illegal Drug Unit in Bihar
New Delhi: What began as a late-night interception of a drug consignment in South Delhi eventually exposed a wider counterfeit pharmaceutical network spanning several states. Investigators from the Delhi Police Crime Branch traced the supply chain from a courier in Delhi to a warehouse in Uttarakhand and finally to an illegal drug manufacturing facility in Bihar, revealing how pharmaceutical raw materials were allegedly diverted for producing fake medicines.
The operation began on a September night when officers of the Crime Branch’s Anti-Narcotics Unit set up surveillance in Lajpat Nagar to intercept a suspected delivery of Tramadol premix. Acting on prior inputs, Sub-Inspector Vikasdeep and Assistant Sub-Inspector Kuldeep coordinated with a trader who placed an order for the substance, hoping to identify the supplier involved in the illegal transaction.
Tramadol premix is a powdered pharmaceutical ingredient used in the manufacture of the opioid analgesic Tramadol, which is prescribed for the treatment of moderate to severe pain. Because of its addictive properties and potential for misuse, the drug falls under the regulatory framework of the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985.
Shortly before midnight, a scooter arrived at the designated location carrying a brown packet. Police officers intercepted the rider, later identified as 49-year-old Anirudh Rai. Upon inspection, the packet tied to the scooter reportedly contained several kilograms of Tramadol premix, following which Rai was detained and questioned.
What initially appeared to be a straightforward seizure soon led investigators to uncover a larger network involved in sourcing and transporting pharmaceutical raw materials. During interrogation, the accused allegedly revealed details that helped the police trace the supply route of the seized substance.
The investigation pointed to a warehouse located in Roorkee, Uttarakhand, which investigators suspect functioned as a storage and distribution hub for bulk pharmaceutical ingredients. Roorkee has developed into a major pharmaceutical manufacturing zone over the past two decades, with several small and medium-scale companies operating in the region after industrial incentives were introduced following the formation of the state.
Police officials stated that a supplier identified as Amit had been operating from the warehouse and was involved in the trading of pharmaceutical raw materials. According to investigators, the facility stored large quantities of chemical ingredients that were supplied to various buyers.
Authorities believe Amit acted as a middleman connecting suppliers of pharmaceutical ingredients with individuals seeking bulk raw materials. Through this supply chain, the Tramadol premix allegedly reached intermediaries in Delhi before being transported by the courier who was intercepted in Lajpat Nagar.
Further investigation led the Crime Branch to an alleged illegal drug manufacturing unit in Bihar. Officials suspect the facility was operated by Tanishq Jha and continued functioning despite the expiry of its manufacturing licence.
According to investigators, the factory already possessed the required machinery and labour necessary for pharmaceutical production. Officials suspect that once legitimate manufacturing slowed or regulatory approvals lapsed, the operators shifted towards producing counterfeit medicines due to the higher profits associated with illegal production.
Authorities also alleged that the facility manufactured counterfeit medicines, including cough syrups packaged under the labels of well-known pharmaceutical brands. These products were reportedly sold in wholesale markets at lower prices, making them difficult to differentiate from genuine medicines within the distribution chain.
Investigators believe the Tramadol premix seized in Delhi had been ordered months earlier through the Roorkee network and was intended to be converted into tablets at the Bihar facility. Officials suspect that the finished drugs would then be distributed through illegal channels across various markets.
Police officials noted that such cases often represent only the final stage of a much larger underground pharmaceutical supply chain involving raw-material suppliers, transporters, and illegal manufacturing units.
Authorities warned that counterfeit medicines pose a serious threat to public health because such products may contain incorrect ingredients, unsafe dosages, or harmful contaminants that can endanger patients.
According to a recent media report by The Indian Express, investigators believe the case may reveal a wider inter-state network engaged in the illegal manufacture and distribution of counterfeit medicines.
